International Congress London 2016

Saturday, 03.09.2016 Sunday, 04.09.2016 Monday, 05.09.2016 Tuesday, 06.09.2016 Wednesday, 07.09.2016		Sponsored symposia: Industry Evening Mini Symposium at ERS 2016: “Challenges in the management of non-CF bronchiectasis”

Citations should be made in the following way: Authors. Title. Eur Respir J 2016; 48: Suppl. 60, abstract number.

ME2 New treatment approaches for idiopathic pulmonary fibrosis

Meet the expert
Aims: To review the drug development landscape for idiopathic pulmonary fibrosis (IPF) in the light of the newly approved anti-fibrotic drugs pirfenidone and nintedanib; and to discuss the preclinical, methodological, and clinical challenges in IPF drug development.

How to access educational materials from mobile devices

Download all media

New treatment approaches for IPF Luca Richeldi (Southampton, United Kingdom)